Qurient, Inc.

Qurient, Inc.

Innovation for Unmet Medical Needs

Founded 2008 27 employees Post-IPO Equity Biotechnology, Health and Wellness

Qurient, Inc. is a biotech startup that was founded in 2008 with a mission to address unmet medical needs through innovation. The company operates using a unique virtual biotech model known as 'Network R&D', which covers both clinical development phases and early discovery research. This model enables Qurient to efficiently innovate in various therapeutic areas by leveraging an expert network. The company primarily focuses on creating value from early discovery to clinical proof-of-concept, aiming for a more efficient organizational structure and clear innovation focus. Qurient believes that late-stage development is better suited for a fully integrated pharmaceutical/biotech industry with proper marketing functions in the therapeutic area. Qurient's commitment to providing innovative solutions for unmet medical needs aligns with its goal to create concrete value for shareholders. The last investment the company received was a Post-IPO Equity investment at 01 January 2018 from Alpenroute Asset Management. Operating in the Biotechnology and Health and Wellness industries, Qurient is positioned at the forefront of the biotech industry in Korea and has the potential to make significant contributions to global healthcare.

Funding Stage	Amount	Investors	Lead Investors	Date
Post IPO Equity	Undisclosed	1	Alpenroute Asset Management	01 Jan 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Post IPO Equity

Undisclosed

Alpenroute Asset Management

01 Jan 2018

FAQ About Qurient, Inc.

Innovation for Unmet Medical Needs

Qurient, Inc. was founded in 2008.

Qurient, Inc. operates in Biotechnology and Health and Wellness. Its work centres on biotech industry, virtual biotech model, Network R&D and clinical development.

Qurient, Inc. has approximately 27 employees.

Qurient, Inc. has completed 1 funding round. The latest funding stage is Post-IPO Equity.

Top alternatives and competitors to Qurient, Inc. include Gossamer Bio, Exalys Therapeutics, Antharis Therapeutics, Inc., Apollo Therapeutics, BlossomHill Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Qurient, Inc. and Gossamer Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Qurient, Inc.

Funding Rounds & Investors (1)

Qurient, Inc. Alternatives & Competitors

FAQ About Qurient, Inc.